tradingkey.logo

BRIEF-EMA's CHMP Adopts Indication Extension For Abrysvo To Include Adults From 18 Years

ReutersFeb 28, 2025 2:36 PM

- EMA's CHMP:

  • CHMP ADOPTED EXTENSION TO EXISTING INDICATION TO EXTEND USE OF ABRYSVO TO ADULTS FROM 18 YEARS OF AGE

Source text: [ID:]

Further company coverage: PFE.N

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI